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We have previously reported the isolation and characterization of an influenza virus variant with decreased sensitivity to
the neuraminidase-specific inhibitor zanamivir. This variant, which has a mutation in the active site, Glu 119 Gly (E119G), has
the same specific activity as the wild-type neuraminidase (NA), but is inherently unstable, as measured by loss of both
enzyme activity and NC10 monoclonal antibody reactivity. However, despite the instability of the NA, replication of the virus
in liquid culture is not adversely affected. We demonstrate here that in addition to enhanced temperature sensitivity the
mutant NA was significantly more sensitive to formaldehyde and to specimen preparation for electron microscopy. Substrate,
inhibitor, or monoclonal antibodies stabilized the NA against all methods of denaturation. These results suggest that the
instability of the variant is primarily at the level of polypeptide chain folding rather than at the level of association of
monomers into tetramers. Furthermore the presence of high levels of substrate, either cell or virus associated, may be
sufficient to stabilize the NA during virus replication. © 1998 Academic Press
INTRODUCTION
Influenza is still a major disease of the upper respira-
tory tract in humans and some other animals. Influenza
virus has two surface glycoproteins, neuraminidase (NA)
and hemagglutinin (HA). The HA binds to target recep-
tors on host cells and the NA destroys these HA recep-
tors, allowing the elution of progeny virus particles from
the surface of infected cells. It is also thought that the NA
facilitates passage of virus through the protective mucin
covering target cells, by desialylation of the sialic acid-
rich mucin (Klenk and Rott, 1988). Inhibition of the NA
would be useful as an anti-influenza strategy, as this
would slow the spread of virus infection. The NA active
site is highly conserved in all strains of influenza (Vargh-
ese et al., 1983; Colman et al., 1983; Burmeister et al.,
1992). An NA-specific inhibitor 4-guanidino-Neu5Ac2en,
or zanamivir, was designed (von Itzstein et al., 1993,
1994) based on the X-ray structure of influenza virion-
derived NA (Varghese and Colman, 1991) and its com-
plex with sialic acid (Varghese et al., 1992). Zanamivir,
which has potent anti-viral activity both in vitro and in
vivo (von Itzstein et al., 1993; Woods et al., 1993; Hayden
et al., 1994), is currently in clinical trials (Hayden et al.,
1997). We have reported the emergence of influenza
variants resistant to zanamivir, having mutations in the
HA and NA genes (Blick et al., 1995; McKimm-Breschkin
et al., 1996a). One particular NA variant, E119G, has been
reported by three different groups (Blick et al., 1995;
Staschke et al., 1995; Gubareva et al., 1996). Glu 119 is
one of the conserved residues in the active site and the
occurrence of this variant suggests that this residue is
tolerant of a change that preserves activity, but reduces
drug binding. We reported earlier the crystal structure of
this mutant NA and inhibitor/NA complex and showed
that apart from the mutation of Glu to Gly at 119 and the
additional water molecule replacing the Glu side chain in
the mutant enzyme, no significant differences in the
protein structure were evident in this region or else-
where. The specific activity of the mutant E119G enzyme
was similar to that of the wild-type enzyme (Blick et al.,
1995). However, this mutant was inherently unstable at
high and low temperatures, either on the virion or as
purified neuraminidase (McKimm-Breschkin et al.,
1996b). Further experiments revealed that the mutant
virus gave a smaller plaque size which was rescued by
addition of exogenous bacterial NA (Blick et al., in press).
To determine whether the NA instability resulted in
poorer replication we followed the kinetics of virus rep-
lication of the mutant (Blick et al. (in press) and we
present results here on the kinetics of synthesis and
transport of the mutant NA. The integrity of virus-derived
NA heads was also investigated by electron microscopy.
Studies on the effects of substrate, inhibitor, or antibody
binding demonstrate that the presence of substrate or
zanamivir and binding of monoclonal antibodies stabi-
lizes the E119G NA.
Others have recently proposed (Colacino et al., 1997)
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that the mutant E119G is impaired in its ability to form
tetramers because of a specific, long-range conforma-
tional effect of the substitution of Glu to Gly, but our data
are more consistent with the instability of the variant
being at the level of polypeptide chain folding of the NA
subunit, as proposed earlier (McKimm-Breschkin et al.,
1996b).
RESULTS
Kinetics of appearance of surface NA in wild-type and
E119G virus-infected cells
Initial experiments were performed on a single micro-
titer plate with cells being fixed (quadruplicate samples)
with formaldehyde at each time point and plates were
then returned to the 37°C incubator, to be removed only
for fixing of cells at subsequent time points. After the last
time point, 7 h pi formaldehyde was added and the
microtiter plate was incubated at 4°C. The sudden ap-
parent increase in levels of native NA (as detected by
NC10 antibody) at the 7-h time point was consistently
observed (Fig. 1). However, as this time point had been
fixed at 4°C, whereas the earlier time points were re-
turned to 37°C, the experiment was repeated with sep-
arate microtiter plates for individual time points, each
being fixed with formaldehyde at 4°C. When fixed at 4°C
for all time points, levels of NC10-reactive, surface NA
were the same for wild-type and mutant virus (Fig. 1). For
cells fixed at either temperature there were similar levels
of surface NA in wild type and mutant virus-infected cells
as detected by the polyclonal RaN9 antibody (results not
shown). These results all suggested that the synthesis
and transport of the NA was similar for the wild-type and
mutant viruses but the mutant NA was differentially sen-
sitive to formaldehyde at 37°C. While the denatured
mutant NA still reacted with the polyclonal RaN9 sera the
conformation-specific antibody NC10 did not recognize
this form.
Effect of formaldehyde on E119G neuraminidase
activity
To investigate the sensitivity of the E119G NA to form-
aldehyde in vitro, wild-type and E119G viruses were
assayed for NA activity after preincubation for 1 h in the
presence of formaldehyde at 0 and 37°C. Table 1 shows
that the E119G virion-associated NA was more sensitive
than the wild-type NA even at 0°C, but this instability was
more pronounced at 37°C.
Substrate protects E119G virion-associated NA from
formaldehyde inactivation
Since we have proposed that the instability arises from
unfolding of the monomers, we investigated if the pres-
ence of substrate could provide any protection from the
denaturing effect of formaldehyde. NA activity on whole
virus was assayed at 37°C with the simultaneous addi-
tion of formaldehyde and substrate. Residual activity was
compared to that after preincubating with formaldehyde
for 1 h at 37°C. When substrate was added at the same
time as formaldehyde there was no loss of enzyme
activity (Table 2). The wild-type virion-associated NA was
also protected by the presence of substrate, but the
stabilizing effect of substrate was more evident in the
case of E119G virion-associated NA.
FIG. 1. Levels of surface NA as detected by NC10 antibody, in
wild-type- and E119G mutant virus-infected cells. (A) Cells fixed and
returned to 37°C except the 7-h time point, which was fixed and
incubated at 4°C. (B) Cells fixed at 4°C for all time points.
TABLE 1
Effect of Formaldehyde on NA Activity in a MUNANA-Based
Enzyme Assay
Virus





Wild type 74% 38%
E119G 51% ,1%
a Enzyme activity after a 1-h incubation at 37°C.
b Virus was preincubated for 1 h in 1% formaldehyde.
TABLE 2
Stabilization by MUNANA Substrate of Formaldehyde
Inactivation of E119G
Virus






Wild type 87% 50%
E119G 94% 7%
a NA activity after a 1-h incubation at 37°C.
b Virus was pretreated at 37°C for 1 h in 1% formaldehyde.
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Presence of substrate and the inhibitor zanamivir
protects the E119G virion-associated NA from
thermal instability
McKimm-Breschkin et al. (1996a) recently showed that
the E119G NA is unstable to high and low temperatures.
The observation that presence of substrate protected the
E119G NA from formaldehyde inactivation led us to test
whether substrate would stabilize the mutant NA from
thermal inactivation. However, as the substrate would be
metabolized, we added MUNANA far in excess of the
concentrations normally used in an enzyme assay. In
addition, we tested the stabilizing effect of the inhibitor
zanamivir, which also binds the active site pocket. More
than 50% of the enzyme activity or NC10 reactivity was
lost after incubation for 1 h at 50°C. However, in the
presence of either substrate or inhibitor there was only a
small decrease in either enzyme activity or NC10 reac-
tivity under the same conditions. At the concentrations
used the substrate and inhibitor would occupy the active
site (Varghese et al., 1992, 1995). Table 3 shows clearly
that binding of substrate or inhibitor protected the E119G
NA from thermal instability.
Presence of monoclonal antibodies NC10 and NC41
stabilizes the E119G NA
To further our understanding of the destabilizing effect
of this mutation on the NA structure, we examined
whether external stabilization of the monomers would
also protect against thermal denaturation. For this pur-
pose residual enzyme activity was determined after in-
cubation at 50°C for 1 h in the presence of the NC10 or
NC41 monoclonal antibodies. The NC10 and NC41 anti-
bodies have been characterized in detail elsewhere
(Webster et al., 1987). Three-dimensional structures of
their Fab fragments complexed to wild-type neuramini-
dase have been described (Tulip et al., 1992, Malby et al.,
1994) and illustrate that the binding sites for both anti-
bodies involve polypeptide segments which derive from
a single covalent subunit of the neuraminidase tetramer.
For NC10, however, there are direct atomic contacts
between the antibody and carbohydrate components
from an adjacent monomer (Malby et al., 1994). Although
these contacts are at the extreme periphery of the anti-
body–antigen interface and are unlikely to contribute
significantly to the binding energy, the NC10 binding
surface is properly described as bridging adjacent cova-
lent structures within the tetramer. The NC41 antibody
comes close to, but makes no such contact with, carbo-
hydrate on the adjacent monomer (Tulip et al., 1992). In
this case NC41 binding provides an unambiguous read-
out of the integrity of the monomer structure and cannot
be held to depend on the presence of tetramers.
Both monoclonal antibodies NC10 and NC41 stabilized
E119G NA against thermal denaturation (Table 3). The
control antibody, 17B, showed very little protection. Cou-
pled with the substrate and inhibitor results this demon-
strates that either internal or external stabilization of the
individual monomers is sufficient to maintain the integrity
of the NA.
Electron microscopy of the wild-type and E119G
mutant NA heads
To investigate the integrity of the NA, redissolved crys-
tals of NA heads were examined by electron microscopy,
after uranyl formate staining. The wild-type sample con-
sisted of homogenous particles with the characteristic
appearance of NA tetrameric heads (Fig. 2C). Despite
being prepared from redissolved crystals which are
known to consist of tetramers, the E119G NA appeared
as a heterogenous population with particles of different
sizes (Fig. 2A), mostly smaller than the NA tetramer. Due
to its unstable nature it was possible that the preparation
of the specimen for electron microscopy had resulted in
denaturation of the NA. Since our results suggested that
either inhibitor or substrate could stabilize the NA, heads
were incubated with zanamivir prior to preparation of the
sample for electron microscopy. Results are presented in
Fig. 2B. The same sample which showed the smaller
sized particles now showed a more homogenous popu-
lation of NA tetramers similar to the wild-type NA.
Calculations of electrostatic complementarity at
monomer–monomer interfaces
The calculated values of electrostatic potential
complementarity (i.e., 1.0 3 Spearman correlation coef-
ficient) at the monomer–monomer interface are 0.55 and
0.54, respectively, for wild-type and E119G mutant in the
fully solvated case, while they are 0.64 and 0.65, respec-
tively, in the partially solvated case.
The electrostatic component of the monomer–mono-
mer binding free energy is calculated to be 1179.56 and
1177.88 kT units for wild-type and E119G, respectively
TABLE 3




a after 1 h at
50°C
NC10 reactivity
a after 1 h at
50°C
Wild type 89% 89%
E119G alone 45% 45%
1 NC10b 85% —
1 NC41b 96% —
1 Anti-N2b 48% —
1 Zanamivir (100 mM) — 84%
1 Substrate (5 mM) — 85%
a Duplicates were within 10% of each other.
b Virus was preincubated at room temperature for 15 min with anti-
body at approximately a 1:1 ratio of NA protein to antibody.
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(where k is the Boltzmann constant and T is the temper-
ature). At 25°C, this difference is only 1.0 kcal mol21, i.e.,
less than the uncertainty in this calculation.
DISCUSSION
We reported earlier the isolation and characterization
of the NA active site mutant E119G (Blick et al., 1995). We
demonstrated that it had the same specific activity as the
wild-type NA, but was unstable to high or low tempera-
tures (McKimm-Breschkin et al., 1996b). In trying to un-
derstand the impact that this mutation has on the virus
replication, we observed that the E119G mutant virus
gave plaques significantly smaller than the wild-type
virus and this plaquing phenotype could be rescued by
the addition of exogenous bacterial NA (Blick et al., in
press). As part of a study to determine if the instability of
the E119G NA affected the kinetics of replication, both
the levels of NA and the kinetics of appearance of intra-
cellular and surface NA were compared to the wild type.
For wild-type- and mutant-infected cells intracellular lev-
els of NA were similar (results not shown). We demon-
strated here that there was little NC10-reactive NA de-
tected on the surface of mutant-infected cells, when cells
were reincubated at 37°C after fixing. In contrast, when
cells were fixed at 4°C the kinetics of NA appearance at
the cell surface, as detected by both monoclonal (NC10)
and polyclonal antibodies showed similar levels of NA
for the mutant- and wild-type-infected cells. These re-
sults are consistent with no difference in replication
kinetics observed in liquid culture for the mutant and
wild-type viruses (Blick et al., in press). Further experi-
ments revealed that the E119G NA was more sensitive to
formaldehyde especially at 37°C, thus accounting for the
differences seen at the 7-h time point since this was only
ever incubated at 4°C.
Formaldehyde or paraformaldehyde is commonly
used as a fixative to study surface proteins by immu-
nofluorescence (Goding, 1996). Its use in this case of
an unstable protein is inappropriate. Our finding cau-
tions researchers about the effect this reagent could
FIG. 2. Electron micrographs of negatively stained NA heads from (A) E119G mutant, (B) E119G mutant preincubated with zanamivir, and (C)
wild-type NWS/G70C virus.
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have on mutant proteins and their recognition by
monoclonal antibodies.
We demonstrated here that stabilization of the individ-
ual monomers either internally by the binding of sub-
strate or inhibitor in the active site or externally by bind-
ing of the monoclonal antibodies NC10 or NC41 main-
tained the integrity of the NA. This supports our earlier
hypothesis that the instability arises from unfolding of the
monomeric subunits (McKimm-Breschkin et al., 1996b).
From these observations emerges a possible explana-
tion for the apparent discrepancy between similar repli-
cation in liquid culture compared to the wild type, but
smaller plaques for the mutant (Blick et al., in press). In
liquid culture there may be sufficient substrate, either
cell or virus-associated, to stabilize the NA and allow
effective virus release. Under plaque assay conditions
substrate would be more limiting, hence there may be
insufficient substrate to stabilize the NA, resulting in less
efficient virus release, slower replication, and a smaller
plaque size.
There has been a recent report that this unstable NA
may exist as monomers (Colacino et al., 1997). Electron
microscopic analysis of the wild-type and E119G mutant
NA revealed that preparations of the mutant enzyme
were heterogenous and consisted of a high proportion of
particles smaller than the tetramers that were seen in the
wild type. Our initial observations were consistent with
those of Colacino et al. (1997). However, since our elec-
tron microscopy grids were prepared from freshly dis-
solved crystals of wild-type and mutant NA we knew
tetrameric species must be present. This suggested that
we were seeing an instability of the mutant NA to the
harsh conditions used for electron microscopy specimen
preparation.
Based on our results that the presence of substrate
and/or inhibitor stabilized the mutant NA, the heads were
therefore preincubated with zanamivir prior to prepara-
tion for electron microscopy. The characteristic tetramers
seen with the mutant in the presence of the inhibitor
zanamivir confirmed that the presence of inhibitor stabi-
lized the mutant NA and that it was present as tetramers,
not as monomers. Colacino et al. (1997) conclude from
their cross-linking studies that, in solution, mutant N9
enzyme consists mostly of monomers. Our previous re-
sults on the instability (McKimm-Breschkin et al., 1996b)
suggest that the prolonged incubations used in the prep-
aration of the NA heads by Colacino et al. (1997) could
lead to denaturation of the mutant NA. We feel that when
there is a high proportion of denatured NA in the purified
E119G NA preparation, the lack of cross-linked material
proves the absence of tetramers but does not support
the presence of naturally occurring monomers in the
mutant. We have looked for possible long-range electro-
static effects at the tetramer interface by computing the
electrostatic complementarity of the interface and the
electrostatic component of the monomer–monomer bind-
ing free energy. Neither calculation supports the hypoth-
esis that the electrostatic contribution to the monomer–
tetramer equilibrium is different in mutant than in wild
type.
In attempting to explain the absence of tetramers of
mutant seen by electron microscopy, Colacino et al.
(1997) have constructed an argument based entirely on
the folded structure of the protein. They correctly observe
that glutamate at position 119 forms a salt bridge to R156
in the wild type and that this bridge is absent in the
E119G variant. However, it understates the complexity of
the problem to conclude that the loss of this ionic inter-
action causes a specific conformational aberration at the
subunit interface leading to dissociation into monomers.
If the ion pair with E119 is critical for the conformation of
R156 and the existence of tetramers, why can E119G
tetramers be stabilized with zanamivir, which aggravates
the ionic environment of R156 by the introduction of a
guanidinium moiety into its neighborhood? This result is
easily comprehended if one argues instead that the
stability of the monomer is impaired by the mutation and
that the population of tetramers is diminished as a result.
Thus presence of substrate, inhibitor, and antibodies
such as NC10 and NC41 will increase the population of
tetramers by increasing the population of correctly folded
monomers. For the E119G variant, the absence of a side
chain at residue 119 has consequences on the unfolded
state, unfolding pathways, and also on the folded struc-
ture and all of these consequences destabilize the folded
structure. We conclude that the electron microscopy re-
sults for the mutant are an artifact of specimen prepara-
tion of an unstable material. Our results suggest that the
instability is primarily at the level of the folded protein
subunit rather than an impairment of the folded subunits
to form tetramers.
MATERIALS AND METHODS
Cells, media and virus
MDCK cells were grown in Dulbecco’s modified Ea-
gle’s medium/Ham’s F12 (Cytosystems, Australia),
supplemented with 10% fetal calf serum (Life Technol-
ogies, USA), glutamine, penicillin/streptomycin (Cyto-
systems, Australia), and fungizone (Squibb, Australia).
The influenza virus NWS/G70C used in this study (re-
ferred to as wild type in the manuscript) was originally
obtained from Robert Webster (St. Jude Children’s
Medical Research Center, Memphis, Tennessee). The
reassortant contains the NA from the A/tern/Australia/
G70C/75 avian virus, and the rest of the genes are
thought to derive from the NWS parent. The NWS/
G70C E119G virus (E119G) mutant was obtained by
passaging the NWS/G70C in MDCK cells in the pres-
ence of zanamivir (Blick et al., 1995).
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Kinetics of appearance of surface NA in wild-type and
E119G virus-infected cells
MDCK cells in 96-well tissue culture plates were in-
fected with wild-type, NWS/G70C, and NWS/G70C E119G
mutant virus at multiplicity of infection (m.o.i.) of approx-
imately 10. Two different experiments were performed.
First, a single microtiter plate was used for all time points
in the experiment. Quadruplicate samples were fixed
with formaldehyde at each time point and the plate was
returned to 37°C incubator, to be removed only for fixing
of cells at subsequent time points. After the last time
point cells were fixed and plates stored at 4°C until
processed for ELISA.
Second, separate plates were used for each time point
and after fixing the plates were held at 4°C. For detection
of NA, the formaldehyde was washed off in PBS and the
surface NA was detected by the monoclonal antibody
NC10 or the anti-N9 polyclonal antibody, RaN9, prepared
by immunization of rabbits with NA heads purified as per
McKimm-Breschkin et al. (1991). Bound NC10 or RaN9
was detected with species-specific HRPO conjugate
(Silenus, Australia) followed by reaction with ABTS sub-
strate (Boehringer Mannheim, Germany). The absor-
bance was read at 405 nm in an ELISA plate reader
(Dynatech Laboratories, USA).
Effect of formaldehyde on E119G neuraminidase
activity
Serial twofold dilutions of wild-type virus and E119G
mutant virus were incubated in the absence or presence
of 1% formaldehyde (final concentration), at 0 or 37°C for
1 h. After incubation the NA enzyme activity was assayed
using MUNANA as substrate by modification of a method
by Potier et al. (1979) as described previously (McKimm-
Breschkin et al., 1996b). The dilution of virus that gave
approximately 50 fluorescence units (FU) in the absence
of formaldehyde was considered to be 100% and this
was used to calculate the residual activity after formal-
dehyde treatment.
Presence of substrate prevents formaldehyde
inactivation of E119G NA
To determine if substrate offered protection against
inactivation by formaldehyde, enzyme activity was as-
sayed with simultaneous addition of formaldehyde and
substrate. Enzyme activity in the absence of formalde-
hyde for a given dilution of virus provided the control.
Presence of substrate and the inhibitor zanamivir
protects the E119G from thermal inactivation
Denaturation of the NA was determined by direct bind-
ing of virus onto ELISA plates and subsequent reaction
with the NC10 monoclonal antibody, since the NC10
antibody recognizes only native NA (McKimm-Breschkin
et al., 1996b). To determine a suitable amount of virus to
use, serial twofold dilutions of the wild-type and E119G
mutant viruses were added to ELISA plates (Dynatech
Laboratories, USA) at 4°C. After overnight incubation, the
unadsorbed virus was sucked off and after blocking,
plates were then incubated with the NC10 antibody at
room temperature for 1 h, to determine the native NA.
Bound NC10 antibody was detected with sheep anti-
mouse HRPO (Silenus, Australia) followed by reaction
with ABTS substrate (Boehringer Mannheim, Germany).
The absorbance was read at 405 nm in an ELISA plate
reader (Dynatech Laboratories, USA). A dilution of virus
was selected which gave an absorbance of approxi-
mately 1.0 after reaction with substrate for 30 min.
To determine whether inhibitor or substrate could sta-
bilize the mutant enzyme against thermal denaturation
zanamivir or MUNANA was added at a final concentra-
tion of 100 mM or 5 mM, respectively, to the appropriate
dilutions of wild-type and mutant viruses. After incuba-
tion at 50°C for 1 h viruses were bound overnight to
ELISA plates and residual NC10-reactive NA was deter-
mined and compared to virus incubated with PBS.
Presence of monoclonal antibodies NC10 and NC41
stabilizes the E119G NA
As we wanted to add approximately a 1:1 ratio of
antibody to NA the amount of purified wild-type NA that
gave approximately 50 FU in an enzyme assay was first
determined. This then allowed us to estimate the micro-
grams of antibody for this number of enzyme units. The
dilutions of wild-type and mutant viruses that gave ap-
proximately 50 FU were then determined. Appropriate
virus dilutions were incubated in the presence and ab-
sence of NC10, NC41, and a control antibody (anti-N2
monoclonal 17B) at 50°C for 1 h. Residual NA activity
was assayed and compared to that in virus samples held
at 0°C.
Electron microscopy
Dissolved crystals of wild-type NA or mutant NA with
or without zanamivir (2 mg of zanamivir was added to 2
mg of protein) were diluted in PBS to concentrations of
the order of 0.05 mg/ml. Droplets of ;3 ml of this solution
were applied to thin carbon film on 700-mesh gold grids
after glow-discharging in nitrogen for 30 s. After 1 min
the excess protein solution was drawn off, an interme-
diate wash of two or three droplets of PBS was applied,
followed by application and withdrawal of four to five
droplets of negative stain, 2% uranyl formate (K and K).
The grids were air-dried and then examined at 60 kV
accelerating voltage in a JEOL 100B transmission elec-
tron microscope at a magnification of 100,0003. Electron
micrographs were recorded on Kodak SO-163 film and
developed in undiluted Kodak D19 developer. For stabi-
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lization experiments approximately 2 mg of E119G NA
heads were incubated with 2 mg of zanamivir.
Calculations of electrostatic complementarity
at monomer–monomer interfaces
The wild-type neuraminidase (pdb code 7nn9; Vargh-
ese et al., 1995) and the E119G mutant neuraminidase
(Blick et al., 1995) structures were used for continuum
electrostatics calculations. The monomer structures
were prepared with Discover version 2.97 (MSI, San
Diego), the buried molecular surfaces (done subsequent
to the generation of the tetramers from the minimized
monomer coordinates with the appropriate rotational
transforms) which specify the interface between the two
monomers were computed with MS (Connolly, 1983), and
the calculation of the electrostatic complementarity and
the binding free energies was done with Delphi version
3.0 (Gilson and Honig, 1988; Nicholls and Honig, 1991).
All steps followed the same procedures and used the
same parameter values as McCoy et al. (1997) in their
study of electrostatic complementarity at protein–protein
interfaces. For example, in the calculations with the lin-
ear Poisson–Boltzmann equation solver, DelPhi, the
PARSE charge and radii parameters (Sitkoff et al., 1994)
were assigned to the protein atoms and the dielectric
boundary and the charges were mapped onto a cubic
grid of 201 3 201 3 201 points per side. The protein
monomers and the monomer–monomer complexes were
modeled with a dielectric constant of 2 while the sur-
rounding solvent was assigned a dielectric constant of
80. Ionic strength was set at zero. Carbohydrate moieties
and crystallographic waters were not included; thus be-
ing modeled as bulk solvent.
For both wild-type and mutant the electrostatic poten-
tial complementarity at the tetramer interface was com-
puted for the two cases, ‘‘fully solvated’’ and ‘‘partially
solvated’’ (see Fig. 1 of McCoy et al., 1997). This was
computed from the Spearman correlation coefficients
(see equations 8 and 10 of McCoy et al., 1997), while the
electrostatic component of the monomer–monomer bind-
ing free energy was calculated from the summation of
the partial desolvation free energies and the interaction
free energy (equation 12 of McCoy et al., 1997).
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